| 13.00 | | | Welcome address, Jean-Olivier Defraigne, Vincent D’Orio |
| | | | | New insights in the aortic pathology
|
| | | | Per Eriskon, Florence Pinet
|
| 13.10 | | | Insights from transcriptomic and proteomic analysis of human aneurysmal cells, Florence Pinet |
| 13.18 | | | A mechanistic link between mechanical stress and inflammation in the progression of aortic diseases, Koichi Yoshimura |
| 13.26 | | | Predicting AAA growth and rupture with a skin biopsy, Kakkhee Yeung
|
| 13.34 | | | A novel diagnostic score for AAA based on plasma D-dimer and myeloperoxidase, Wolf-Hans Eilenberg |
| 13.42 | | | Functional implications and therapeutic relevance of neutrophil extracellular traps in AAA, Christine Brostjan |
| 13.50 | | | Pathological remodeling of vascular smooth muscle in AAA: a therapeutic target? Marc Bailey |
| 13.58 | | | Novel biomarkers of AAA derived from genetic and epigenetic studies, Gregory Jones |
| 14.06 | | | Advanced glycation end products measured by skin autofluorescence are increased in patients with AAA, Clark J. Zeebregts |
| 14.14 | | | Precision medicine in thoracic aortic disease, Julie De Backer |
| 14.22 | | | Discussion |
| | | | |
| | | | | New insights from rodent models of aortic disease |
| | | | Marc Bailey, Lars Maegdefesse |
| 14.40
| | | Critical review of the murine AAA models for 2018, Raphaël Coscas |
| 14.48 | | | 3D ultrasound imaging of murine AAA, Marc Bailey |
| 14.56 | | | Anatomical modifications of the PPE model in mice, Albert Busch |
| 15.04 | | | Lessons learnt from the Guinea pig rat transplantation model of AAA, Eric Allaire |
| 15.12 | | | Therapeutic applications of prostaglandins and thromboxane A2 inhibitors in AAA, Audrey Courtois |
| 15.20 | | | Molecular pathways driving aortic disease in mouse models of ACTA2, MYLK, and MYH11 mutations, Dianna Milewicz |
| 15.28 | | | Discussion |
| | | | |
| 15.50
| | | Coffee break
|
| | | | |
| | | | | Imaging of aortic diseases
|
| | | | Barry Doyle, Joy Roy
|
| 16.20 | | | Quantification of abdominal aortic calcification: inherent measurement errors in current computed tomography imaging, Clark J. Zeebregts |
| 16.28
| | | The discrepancy between the non-automatic and semiautomatic measurement-does it influence outcome? Joy Roy |
| 16.36
| | | Biomechanical wall stress and rupture potential in AAA – data from the MA3RS Trial, Barry Doyle |
| 16.44
| | | Different AAA biomechanical rupture risk assessment approaches. Model fidelity versus diagnostic predictability, Christian Gasser |
| 16.52
| | | Computational biomechanics and morphology of small rAAA – a report from the STAR database, Rebecka Hultgren |
| 17.00
| | | IVUS and CO2 angiogram for aortic disease: strategy to minimize the use of contrast, Igor Sincos |
| 17.08
| | | Discussion |
| | | | |
| | | | | Radiation exposure *
|
| | | | Anders Wanhainen, Clark J. Zeebregts
|
| 17.40 | | | Strategies for optimal occupational radiation protection during vascular intervention, Bijan Modarai |
| 17.50 | | | Effect of MRI on human lymphocyte DNA: myth or reality? Alain Nchimi |
| 18.00 | | | Radiation protection in the endosuite and the importance of correct use of shields, Anders Wanhainen |
| 18.10 | | | Short communication: back to basics, increasing the use of Postero anterior chest radiograph to aid assessment of chest pain for aortic dissection, Sacintha Perera |
| 18.14 | | | Discussion |
| | | | |
| 18.30 | | | End of the sessions
|
| | | | |
| | | | |
| *BELGIAN ATTENDEES – Radiologists, cardiologists and vascular surgeons
Thanks to our partnership with the AFCN (Agence Fédérale de Contrôle Nucléraire), the session on Radiation exposure on Wednesday September 12 at 17.40 can be valued as 1hour of continuing education.
|
| |